On the basis of the Japan Lung Cancer Society Guidelines, pathological diagnosis using NE markers such as chromogranin A, synaptophysin, and NCAM/CD56 are currently used to distinguish SCLC from other lung NE tumors in Japan (64). Here, CHGA is linked to lung cancer.